David M. Cordani, chairman and CEO of The Cigna Group, expressed that these moves were made to “build upon our strengths for ...

In a real-world study, researchers found this data by comparing treatment patterns, healthcare resource utilization, and ...

The early results of trials for two injectable, investigational antiretroviral therapies, VH4524184 and VH4011499, have the ...

Gilead has reported results for a once-yearly intramuscular injection that show blood concentrations of lenacapavir exceeded ...

Celltrion has launched Steqeyma (ustekinumab-stba), its biosimilar of Stelara (ustekinumab), at list price at an 85% discount ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

The new bill would also require state Medicaid programs to report National Average Drug Acquisition Costs (NADAC) as a way to ...

When disasters occur, organizations such as SCAN Health Plan take a holistic approach, considering the needs of members, ...

Prevalence varies by region and is impacted by social stigma, access to preventive medicine and a lack of HIV/AIDS education, ...

An expert discusses considerations for tailoring narcolepsy treatment plans for patients with complex comorbidities or ...

Deborah S. Sarnoff, M.D., talks about the recent breakthrough treatments that are paving the way to treat patients with ...

Celltrion’s Omlyclo is interchangeable with Xolair to treat the same conditions: asthma, chronic rhinosinusitis, food allergy ...